https://alsnewstoday.com/news/results-phase-3-trial-tudca-als-likely-next-year/
0
0
11/25/22 at 1:00pm
Organization
ALS News Today
39 words
0
Comments
Findings from the TUDCA-ALS trial in 337 adults, testing oral TUDCA plus riluzole in slowing ALS progression, are likely in late 2023.
You are the first to view
Create an account
or login to join the discussion